Effects of renin‐angiotensin blockade and APOL1 on kidney function in sickle cell disease

• Jin Han,
• Andrew Srisuwananukorn,
• Binal N. Shah,
• Robert E. Molokie,
• James P. Lash,
• Victor R. Gordeuk,
• Santosh L. Saraf

Affiliations

Jin Han

Department of Pharmacy Practice, College of Pharmacy University of Illinois at Chicago Chicago Illinois USA

Andrew Srisuwananukorn

Division of Hematology and Oncology, Department of Medicine University of Illinois at Chicago Chicago Illinois USA

Binal N. Shah

Division of Hematology and Oncology, Department of Medicine University of Illinois at Chicago Chicago Illinois USA

Robert E. Molokie

Division of Hematology and Oncology, Department of Medicine University of Illinois at Chicago Chicago Illinois USA

James P. Lash

Division of Nephrology, Department of Medicine University of Illinois at Chicago Chicago Illinois USA

Victor R. Gordeuk

Division of Hematology and Oncology, Department of Medicine University of Illinois at Chicago Chicago Illinois USA

Santosh L. Saraf

Division of Hematology and Oncology, Department of Medicine University of Illinois at Chicago Chicago Illinois USA